Skip to main content
Fig. 2 | Radiation Oncology

Fig. 2

From: Ten fraction hypofractionated stereotactic body radiotherapy for the management of ultracentral lung tumors: a retrospective analysis of dosimetry, outcomes, and toxicity

Fig. 2

Kaplan–Meier Survival Curves—Progression Free Survival, A Progression free survival rate as a percent plotted against time in months of all patients, combined. B Progression free survival rate as a percent plotted against time in months of three categories of patients. The patient categories are primary, recurrent, or metastatic

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us